Yoji Hakamata

Seirei Hamamatsu General Hospital

Papers

1

Total Citations

1

H-Index

1

About

Yoji Hakamata is a clinician-researcher specializing in urologic oncology, with a particular focus on rare and diagnostically challenging prostate malignancies. His work bridges advanced imaging and robotic surgery, contributing to the management of uncommon prostate cancers that evade standard detection methods. Hakamata’s most notable contribution is his detailed case report on locally advanced prostate squamous cell carcinoma (SCC)—a tumor accounting for less than 1% of all prostate cancers. In this study, he demonstrated the critical role of PET-CT in identifying abnormal prostate uptake in a patient with a normal PSA level (0.96 ng/mL), leading to a timely diagnosis and subsequent treatment with robot-assisted radical prostatectomy. This work underscores the limitations of PSA screening for rare histologies and highlights the value of multimodal imaging in atypical presentations. While his citation count is currently modest, the paper serves as an important reference for clinicians encountering PSA-discordant prostate lesions. Hakamata’s research contributes to the growing body of evidence that personalized, imaging-guided surgical approaches can improve outcomes for patients with non-adenocarcinoma prostate tumors.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Locally Advanced Prostate Squamous Cell Carcinoma Diagnosed Using <scp>PET</scp>‐<scp>CT</scp> and Treated With Robot‐Assisted Radical Prostatectomy
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Seirei Hamamatsu General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago